Cargando…
Anti-tumor Efficacy Assessment of the Sigma Receptor Pan Modulator RC-106. A Promising Therapeutic Tool for Pancreatic Cancer
Introduction: Pancreatic cancer (PC) is one of the most lethal tumor worldwide, with no prognosis improvement over the past 20-years. The silent progressive nature of this neoplasia hampers the early diagnosis, and the surgical resection of the tumor, thus chemotherapy remains the only available the...
Autores principales: | Tesei, Anna, Cortesi, Michela, Pignatta, Sara, Arienti, Chiara, Dondio, Giulio Massimo, Bigogno, Chiara, Malacrida, Alessio, Miloso, Mariarosaria, Meregalli, Cristina, Chiorazzi, Alessia, Carozzi, Valentina, Cavaletti, Guido, Rui, Marta, Marra, Annamaria, Rossi, Daniela, Collina, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530361/ https://www.ncbi.nlm.nih.gov/pubmed/31156430 http://dx.doi.org/10.3389/fphar.2019.00490 |
Ejemplares similares
-
Pan-Sigma Receptor Modulator RC-106 Induces Terminal Unfolded Protein Response In In Vitro Pancreatic Cancer Model
por: Cortesi, Michela, et al.
Publicado: (2020) -
Exploring the RC-106 Chemical Space: Design and Synthesis of Novel (E)-1-(3-Arylbut-2-en-1-yl)-4-(Substituted) Piperazine Derivatives as Potential Anticancer Agents
por: Listro, Roberta, et al.
Publicado: (2020) -
Sigma Receptors as Endoplasmic Reticulum Stress “Gatekeepers” and their Modulators as Emerging New Weapons in the Fight Against Cancer
por: Tesei, Anna, et al.
Publicado: (2018) -
Rigosertib and Cholangiocarcinoma: A Cell Cycle Affair
por: Malacrida, Alessio, et al.
Publicado: (2021) -
Modeling neoplastic disease with spheroids and organoids
por: Zanoni, Michele, et al.
Publicado: (2020)